In a 16‑year‑old female who accidentally received 90 mg of Vyvanse (lisdexamfetamine), what medication can be used tonight to promote sleep?

Benzodiazepine or Non-Benzodiazepine Hypnotic for Acute Stimulant-Induced Insomnia

For this 16-year-old who received 90 mg of Vyvanse in error, use a short-acting benzodiazepine (triazolam 0.125-0.25 mg) or non-benzodiazepine hypnotic (zolpidem 5-10 mg or zaleplon 5-10 mg) tonight to counteract the stimulant-induced insomnia.

Rationale and Clinical Approach

This is an acute medication error situation requiring immediate management of stimulant-induced insomnia, not chronic insomnia treatment. The 90 mg dose of Vyvanse (lisdexamfetamine) is at the maximum approved dose and will cause significant sleep disruption tonight given its approximately 12-hour duration of action 1.

Why Benzodiazepines or Z-Drugs Are Appropriate

The American Academy of Sleep Medicine guidelines support using:

• Triazolam for sleep onset insomnia (0.25 mg dose studied) 2
• Zolpidem for both sleep onset and maintenance insomnia (10 mg dose) 2
• Zaleplon for sleep onset insomnia (10 mg dose) 2

For a 16-year-old, use lower doses: triazolam 0.125 mg, zolpidem 5 mg, or zaleplon 5 mg initially.

Why NOT Other Options

Melatonin is specifically NOT recommended - the AASM guidelines explicitly suggest clinicians NOT use melatonin for sleep onset or maintenance insomnia 2. While melatonin is commonly used in children with ADHD on stimulants 3, 4, this is for chronic management, not acute overdose situations.

Diphenhydramine (Benadryl) is NOT recommended - guidelines explicitly advise against using diphenhydramine for insomnia 2.

Trazodone is NOT recommended - guidelines suggest NOT using trazodone for sleep onset or maintenance insomnia 2.

Critical Safety Considerations

Cardiac Monitoring Required

The Vyvanse FDA label warns about cardiovascular risks including increased blood pressure, heart rate, and potential for serious cardiac events 5. Before administering any sleep medication:

• Check vital signs (BP, heart rate)
• Assess for chest pain, palpitations, or shortness of breath
• If cardiac symptoms present, this becomes an emergency requiring immediate evaluation

Psychiatric Monitoring

Vyvanse can cause new or worsening psychiatric symptoms including anxiety, agitation, or psychotic symptoms 5. If the patient is experiencing significant anxiety or agitation from the stimulant overdose, a benzodiazepine serves dual purposes (anxiolysis and sleep induction).

Duration of Effect

Lisdexamfetamine has a duration of approximately 12 hours 1. The patient will likely experience insomnia tonight and possibly residual effects tomorrow morning. Plan for sleep hygiene counseling and potential need for repeat dosing tomorrow night if insomnia persists.

Practical Algorithm

1. Assess current status (4-6 hours post-ingestion):

   • Vital signs (HR, BP)
   • Psychiatric symptoms (anxiety, agitation, psychosis)
   • Cardiac symptoms (chest pain, palpitations)

2. If hemodynamically stable with no cardiac symptoms:

   • Give triazolam 0.125 mg OR zolpidem 5 mg OR zaleplon 5 mg at bedtime
   • If significant anxiety present, favor triazolam for anxiolytic properties

3. If tachycardia/hypertension but no chest pain:

   • Consider cardiology consultation
   • Benzodiazepine may help reduce sympathetic tone
   • Monitor closely

4. If cardiac symptoms present:

   • Emergency evaluation takes priority over sleep management
   • Do not give sleep medication until cardiac stability confirmed

Common Pitfalls to Avoid

• Don't use adult doses - this is an adolescent; start with half the adult dose
• Don't give melatonin - insufficient evidence and not guideline-recommended for acute insomnia 2
• Don't ignore cardiovascular assessment - stimulant overdose can cause serious cardiac events 5
• Don't use antihistamines - explicitly not recommended by guidelines 2
• Don't assume one night of medication is sufficient - the stimulant effect may persist, requiring sleep support for 1-2 additional nights

The evidence strongly supports short-acting benzodiazepines or Z-drugs for acute insomnia management 2, and this acute stimulant overdose situation requires immediate pharmacologic intervention rather than behavioral approaches alone.